Nivo ipi mesothelioma
Nivolumab (Nivo) and Ipilimumab (Ipi) are two immunotherapy drugs that have shown promise in treating mesothelioma, particularly in clinical trials and research settings. Here’s a brief overview of these drugs and their role in mesothelioma treatment: Nivolumab (Opdivo) Mechanism of Action: Clinical Use: Potential Side Effects: Ipilimumab (Yervoy) Mechanism of Action: Clinical Use: Potential Side … Read more